申请人:Sankyo Company Limited
公开号:EP0353047A2
公开(公告)日:1990-01-31
Compounds of formula (I):
[in which: R¹ and R² are hydrogen, optionally substituted alkyl, cycloalkyl, alkenyl, aralkyl, arylalkenyl, aryl, aromatic heterocyclic, cyano or halogen: R³ is hydrogen, optionally substituted alkyl, aralkyl or acyl; R⁴ and R⁵ are hydrogen, optionally substituted alkyl, cycloalkyl, alkenyl, aralkyl, arylalkenyl, aryl or aromatic heterocyclic]; and pharmaceutically acceptable salts thereof are analgesics and anti-inflammatory agents as well having anti-ulcer and 5-lipoxygenase inhibitory activities.
式(I)化合物:
其中R¹ 和 R² 是氢、任选取代的烷基、环烷基、烯基、芳烷基、芳烯基、芳基、芳杂环基、氰基或卤素:R³是氢、任选取代的烷基、芳烷基或酰基;R⁴和R⁵是氢、任选取代的烷基、环烷基、烯基、芳烷基、芳烯基、芳基或芳香杂环基];其药学上可接受的盐类是镇痛剂和消炎剂,并具有抗溃疡和 5-脂氧合酶抑制活性。